Anti-Toxoplasma gondii antibody (ab23507)
Key features and details
- Goat polyclonal to Toxoplasma gondii
- Suitable for: ICC/IF
- Reacts with: Toxoplasma gondii
- Isotype: IgG
Overview
-
Product name
Anti-Toxoplasma gondii antibody
See all Toxoplasma gondii primary antibodies -
Description
Goat polyclonal to Toxoplasma gondii -
Host species
Goat -
Specificity
Purified tachyzoites. -
Tested applications
Suitable for: ICC/IFmore details -
Species reactivity
Reacts with: Toxoplasma gondii -
Immunogen
Tissue, cells or virus corresponding to Toxoplasma gondii Toxoplasma gondii. RH strain of Toxoplasma gondii.
-
General notes
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle. -
Storage buffer
pH: 7.20
Preservative: 0.1% Sodium azide
Constituent: 0.0268% PBS -
Concentration information loading...
-
Purity
Proprietary Purification -
Purification notes
>95% pure. -
Clonality
Polyclonal -
Isotype
IgG -
Research areas
Associated products
-
Compatible Secondaries
-
Isotype control
-
Recombinant Protein
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab23507 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
ICC/IF |
Notes |
---|
Indirect immunoflurescence.
Not tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
Target
-
Relevance
Toxoplasma is a crescent shaped sporozoan that lives as an intracellular parasite in various tissues of many vertebrates and completes its life cycle in a single host. Its life cycle includes two phases called the intestinal (or enteroepithelial) and extraintestinal phases. The intestinal phase produces oocysts and occurs only in cats, wild as well as domesticated. The extraintestinal phase occurs in all infected animals including cats, and produces tachyzoites (actively proliferating trophozoites) and eventually, bradyzoites (slowly growing trophozoites) or zoitocysts. Infection due to Toxoplasma gondii occurs in pregnant women where a variable degree of immunosuppression may exist or in patients receiving immunosuppressive drug therapy. Toxoplasma infects tissue of the GI tract where an active infection is accompanied by fever and enlargement of the spleen. Symptoms of toxoplasmosis are generally mild but severe infection of lymph nodes may occur. Congenital toxoplasmosis, in which the maternal infection is transmitted during pregnancy, can produce blindness or mental retardation in the newborn. -
Database links
- SwissProt: P13664 Toxoplasma gondii
-
Alternative names
- T. gondii antibody
Protocols
Datasheets and documents
-
SDS download
-
Datasheet download
References (2)
ab23507 has been referenced in 2 publications.
- Virreira Winter S et al. Determinants of GBP Recruitment to Toxoplasma gondii Vacuoles and the Parasitic Factors That Control It. PLoS One 6:e24434 (2011). ICC/IF ; Toxoplasma gondii . PubMed: 21931713
- Khaminets A et al. Coordinated loading of IRG resistance GTPases on to the Toxoplasma gondii parasitophorous vacuole. Cell Microbiol 12:939-61 (2010). ICC/IF ; Toxoplasma gondii . PubMed: 20109161